Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Kristi Snead"'
Publikováno v:
Cancer Chemotherapy and Pharmacology. 42:149-154
Bleomycin is an antitumor agent which is a mixture of glycopeptides containing at least 55-75% bleomycin A2 and 25-32% bleomycin B2 fractional composition. Two bleomycin formulations, bleomycin sulfate, USP (Blenoxane, Bristol-Myers Squibb Oncology,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fba0baa8d33abbc35439d889a557bf0
https://doi.org/10.1007/s002800050798
https://doi.org/10.1007/s002800050798
Autor:
David S. Alberts, Sydney E. Salmon, Katerina Dvorakova, G. Robert Pettit, Robert T. Dorr, Kristi Snead
Publikováno v:
Investigational new drugs. 14(2)
The tubulin-binding natural product combretastatin A-4 (CA-4) was tested for antitumor activity against fresh human tumors in vitro and 2 mouse tumors, both in vitro and in vivo. In colony forming assays using 10% fetal bovine serum, CA-4 was inhibit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc7a664b14cec7f87564b84e238de50c
https://pubmed.ncbi.nlm.nih.gov/8913833
https://pubmed.ncbi.nlm.nih.gov/8913833